Home/Filings/4/0001214659-18-004993
4//SEC Filing

Wasoff Evan L 4

Accession 0001214659-18-004993

CIK 0001625288other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 3:27 PM ET

Size

6.1 KB

Accession

0001214659-18-004993

Insider Transaction Report

Form 4
Period: 2018-07-25
Wasoff Evan L
Chief Financial Officer
Transactions
  • Award

    Stock options (right to buy)

    2018-07-25+420,000420,000 total
    Exercise: $0.54From: 2018-07-25Exp: 2025-07-25Common Stock (420,000 underlying)
Holdings
  • Common Stock

    1,000,000
Footnotes (2)
  • [F1]35,000 options vested immediately, with the remainder vesting monthly over the next 11 months beginning August 1, 2018.
  • [F2]Granted under the Company's 2018 Equity Incentive Plan.

Issuer

Intiva BioPharma Inc.

CIK 0001625288

Entity typeother

Related Parties

1
  • filerCIK 0001719738

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 3:27 PM ET
Size
6.1 KB